Table 2. Characteristics of Participating Sites by World Health Organization Geographic Region.
| Characteristic | Sites, No. (%) | ||||||
|---|---|---|---|---|---|---|---|
| Overall | Africaa | Americas | Eastern Mediterranean | Europe | South-East Asia | Western Pacific | |
| Distribution of contributing sites | 1437 of 1437 (100) | 642 of 1437 (44.7) | 174 of 1437 (12.1) | 70 of 1437 (4.9) | 467 of 1437 (32.5) | 41 of 1437 (2.9) | 44 of 1437 (3.1) |
| In a country with low, lower-middle, or upper-middle income | 789 of 1437 (54.9) | 642 of 642 (100) | 23 of 174 (13.2) | 63 of 70 (90.0) | 6 of 467 (1.3) | 41 of 41 (100) | 14 of 44 (31.8) |
| In a region with ≥80% of severe COVID-19 cases treated in the ICU | 384 of 806 (47.6) | 7 of 11 (63.6) | 93 of 174 (53.4%) | 70 of 70 (100) | 140 of 467 (30.0) | 36 of 41 (87.8) | 38 of 44 (86.4) |
| In a region with at least 1 severe or critical COVID-19 case treated with invasive mechanical ventilation | 699 of 806 (86.7) | 9 of 11 (81.8) | 168 of 174 (96.6) | 70 of 70 (100) | 372 of 467 (79.6) | 40 of 41 (97.6) | 40 of 44 (90.9) |
Abbreviation: ICU, intensive care unit.
a
Patients from South Africa were treated across 631 hospitals. Although information was obtained regarding the treatments and outcomes of individual patients, the distribution of patients across South African sites, as well as site-level characteristics, are missing. Accordingly, 631 sites from South Africa were removed from these proportions.